4-Hydroxynonenal modulation of p53 family gene expression in the SK-N-BE neuroblastoma cell line

Free Radical Biology and Medicine

Volumn 38, Issue 2, 2005, Pages 215-225

  Laurora, Stefano ^a   Tamagno, Elena ^a   Briatore, Federica ^a   Bardini, Paola ^a   Pizzimenti, Stefania ^a   Toaldo, Cristina ^a   Reffo, Patrizia ^a   Costelli, Paola ^a   Dianzani, Mario U ^a   Danni, Oliviero ^a   Barrera, Giuseppina ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

4 Hydroxynonenal; Apoptosis; Cell growth; Free radicals; p53; p63; p73; SK N BE human neuroblastoma cell line

Indexed keywords

4 HYDROXYNONENAL; CYCLINE; PROTEIN BAX; PROTEIN P21; PROTEIN P53; PROTEIN P63; PROTEIN P73;

APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; MODULATION; MULTIGENE FAMILY; NEUROBLASTOMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION;

ALDEHYDES; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BLOTTING, WESTERN; CELL CYCLE; CELL CYCLE PROTEINS; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL PROLIFERATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYSTEINE PROTEINASE INHIBITORS; DNA-BINDING PROTEINS; FLOW CYTOMETRY; GENES, TUMOR SUPPRESSOR; HL-60 CELLS; HUMANS; LIPID METABOLISM; MICROSCOPY, FLUORESCENCE; NEUROBLASTOMA; NUCLEAR PROTEINS; PEROXIDES; PHOSPHOPROTEINS; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-BCL-2; RETINOBLASTOMA PROTEIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TIME FACTORS; TRANS-ACTIVATORS; TRETINOIN; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS;

EID: 20844451539     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2004.10.014     Document Type: Article

References (41)

1. M.U. Dianzani 4-Hydroxynonenal from pathology to physiology Mol. Aspects Med. 24 2003 263 272
2. H. Esterbauer, R.J. Schaur, and H. Zollner Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes Free Radic. Biol. Med. 11 1991 81 128
3. M.U. Dianzani, G. Barrera, and M. Parola 4-Hydroxy-2,3-nonenal as a signal for cell function and differentiation Acta Biochim. Pol. 46 1999 6 75
4. M. Curzio, H. Esterbauer, C. Di Mauro, G. Cecchini, and M.U. Dianzani Chemotactic activity of the lipid peroxidation product 4-hydroxynonenal and homologous hydroxyalkenals Biol. Chem. Hoppe Seyler 367 1986 321 329
5. G. Barrera, S. Pizzimenti, S. Laurora, E. Moroni, B. Giglioni, and M.U. Dianzani 4-Hydroxynonenal affects pRb/E2F pathway in HL-60 human leukemic cells Biochem. Biophys. Res. Commun. 295 2002 267 275
6. Y. Yang, R. Sharma, A. Sharma, S. Awasthi, and Y.C. Awasthi Lipid peroxidation and cell cycle signaling: 4-hydroxynonenal, a key molecule in stress mediated signaling Acta Biochim. Pol. 50 2003 319 336
7. G. Barrera, C. Di Mauro, R. Muraca, D. Ferrero, G. Cavalli, V.M. Fazio, and L. Paradisi Induction of differentiation in human HL-60 cells by 4-hydroxynonenal, a product of lipid peroxidation Exp. Cell Res. 197 1991 148 152
8. N. Calonghi, C. Boga, C. Cappadone, E. Pagnotta, C. Bertucci, J. Fiori, and L. Masotti Cytotoxic and cytostatic effects induced by 4-hydroxynonenal in human osteosarcoma cells Biochem. Biophys. Res. Commun. 293 2002 1502 1507
9. G. Barrera, S. Pizzimenti, A. Serra, C. Ferretti, V.M. Fazio, G. Saglio, and M.U. Dianzani 4-Hydroxynonenal specifically inhibits c-myb but does not affect c-fos expression in HL-60 cells Biochem. Biophys. Res. Commun. 227 1996 589 593
10. G. Barrera, R. Muraca, S. Pizzimenti, A. Serra, C. Rosso, G. Saglio, M.G. Farace, V.M. Fazio, and M.U. Dianzani Inhibition of c-myc expression induced by 4-hydroxynonenal, a product of lipid peroxidation, in the HL-60 human leukemic cell line Biochem. Biophys. Res. Commun. 203 1994 553 561
11. S. Pizzimenti, G. Barrera, M.U. Dianzani, and S. Brusselbach Inhibition of D1, D2, and A-cyclin expression in HL-60 cells by the lipid peroxidation product 4-hydroxynonenal Free Radic. Biol. Med. 26 1999 1578 1586
12. D. Wolf, and V. Rotter Major deletions in the gene encoding the p53 tumor antigen cause lack of p53 expression in HL-60 cells Proc. Natl. Acad. Sci. USA 82 1985 790 794
13. T. Hunter, and J. Pines Cyclins and cancer. II. Cyclin D and CDK inhibitors come of age Cell 79 1994 573 582
14. L. Zhang, J. Yu, B.H. Park, K.W. Kinzler, and B. Vogelstein Role of BAX in the apoptotic response to anticancer agents Science 290 2000 989 992
15. M. Kaghad, H. Bonnet, A. Yang, L. Creancier, J.C. Biscan, A. Valent, A. Minty, P. Chalon, J.M. Lelias, X. Dumont, P. Ferrara, F. McKeon, and D. Caput Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers Cell 90 1997 809 819
16. A. Yang, M. Kaghad, Y. Wang, E. Gillett, M.D. Fleming, V. Dotsch, N.C. Andrews, D. Caput, and F. McKeon p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities Mol. Cell 2 1998 305 316
17. M. Levrero, V. De Laurenzi, A. Costanzo, J. Gong, J.Y. Wang, and G. Melino The p53/p63/p73 family of transcription factors: overlapping and distinct functions J. Cell Sci. 113 2000 1661 1670
18. A. Yang, and F. McKeon P63 and P73: P53 mimics, menaces and more Nat. Rev. Mol. Cell. Biol. 1 2000 199 207
19. M. Hollstein, D. Sidransky, B. Vogelstein, and C.C. Harris p53 mutations in human cancers Science 253 1991 49 53
20. C. Caron de Fromentel, and T. Soussi TP53 tumor suppressor gene: a model for investigating human mutagenesis Genes Chromosomes Cancer 4 1992 1 15
21. K. Vogan, M. Bernstein, J.M. Leclerc, L. Brisson, J. Brossard, G.M. Brodeur, J. Pelletier, and P. Gros Absence of p53 gene mutations in primary neuroblastomas Cancer Res. 53 1993 5269 5273
22. U.M. Moll, M. LaQuaglia, J. Benard, and G. Riou Wild-type p53 protein undergoes cytoplasmic sequestration in undifferentiated neuroblastomas but not in differentiated tumors Proc. Natl. Acad. Sci. USA 92 1995 4407 4411
23. K. Zarkovic 4-Hydroxynonenal and neurodegenerative diseases Mol. Aspects Med. 24 2003 293 303
24. K.J. Barnham, C.L. Masters, and A.I. Bush Neurodegenerative diseases and oxidative stress Nat. Rev. Drug Discovery 3 2004 205 214
25. 2 and 4-hydroxynonenal mediate amyloid beta-induced neuronal apoptosis by activating JNKs and p38MAPK Exp. Neurol. 180 2003 144 155
26. F. Condorelli, M.A. Sortino, A.M. Stella, and P.L. Canonico Relative contribution of different receptor subtypes in the response of neuroblastoma cells to tumor necrosis factor-alpha J. Neurochem. 75 2000 1172 1179
27. J.Z. Cheng, R. Sharma, Y. Yang, S.S. Singhal, A. Sharma, M.K. Saini, S.V. Singh, P. Zimniak, S. Awasthi, and Y.C. Awasthi Accelerated metabolism and exclusion of 4-hydroxynonenal through induction of RLIP76 and hGST5.8 is an early adaptive response of cells to heat and oxidative stress J. Biol. Chem. 276 2001 41213 41223
28. D.H. Hyun, M.H. Lee, B. Halliwell, and P. Jenner Proteasomal dysfunction induced by 4-hydroxy-2,3-trans-nonenal, an end-product of lipid peroxidation: a mechanism contributing to neurodegeneration? J. Neurochem. 83 2002 360 370
29. J.F. Kalinich, R. Ramakrishnan, D.E. McClain, and N. Ramakrishnan 4-Hydroxynonenal, an end-product of lipid peroxidation, induces apoptosis in human leukemic T- and B-cell lines Free Radic. Res. 33 2000 349 358
30. D. Zanetti, G. Poli, B. Vizio, B. Zingaro, E. Chiarpotto, and F. Biasi 4-Hydroxynonenal and transforming growth factor-beta1 expression in colon cancer Mol. Aspects Med. 24 2003 273 280
31. A. Sovic, S. Borovic, I. Loncaric, T. Kreuzer, K. Zarkovic, T. Vukovic, G. Wag, R. Hrascan, R. Wintersteiger, R. Klinger, N. Zurak, R.J. Schaub, and N. Zarkovic The carcinostatic and proapoptotic potential of 4-hydroxynonenal in HeLa cells is associated with its conjugation to cellular proteins Anticancer Res. 21 2001 1997 2004
32. D. Schwartz, and V. Rotter p53-dependent cell cycle control: response to genotoxic stress Semin. Cancer Biol. 8 1998 325 336
33. C. Prives, and P.A. Hall The p53 pathway J. Pathol. 187 1999 112 126
34. M. Oren Decision making by p53: life, death and cancer Cell Death Differ. 10 2003 431 442
35. M. Osada, M. Ohba, C. Kawahara, C. Ishioka, R. Kanamaru, I. Katoh, Y. Ikawa, Y. Nimura, A. Nakagawara, M. Obinata, and S. Ikawa Cloning and functional analysis of human p51, which structurally and functionally resembles p53 Nat. Med. 4 1998 839 843
36. H. Schmale, and C. Bamberger A novel protein with strong homology to the tumor suppressor p53 Oncogene 15 1997 1363 1367
37. K. Tieu, D.M. Zuo, and P.H. Yu Differential effects of staurosporine and retinoic acid on the vulnerability of the SH-SY5Y neuroblastoma cells: involvement of BCL-2 and p53 proteins J. Neurosci. Res. 58 1999 426 435
38. V. De Laurenzi, G. Raschella, D. Barcaroli, M. Annicchiarico-Petruzzelli, M. Ranalli, M.V. Catani, B. Tanno, A. Costanzo, M. Levriero, and G. Melino Induction of neuronal differentiation by p73 in a neuroblastoma cell line J. Biol. Chem. 275 2000 15226 15231
39. A. Shimada, S. Kato, K. Enjo, M. Osada, Y. Ikawa, K. Kohno, M. Obinata, R. Kanamaru, S. Ikawa, and C. Ishioka The transcriptional activities of p53 and its homologue p51/p63: similarities and differences Cancer Res. 59 1999 2781 2786
40. Y. Nakamura, T. Ozaki, H. Koseki, A. Nakagawara, and S. Sakiyama Accumulation of p27 KIP1 is associated with BMP2-induced growth arrest and neuronal differentiation of human neuroblastoma-derived cell lines Biochem. Biophys. Res. Commun. 307 2003 206 213
41. L.J. Wainwright, A. Lasorella, and A. Iavarone Distinct mechanisms of cell cycle arrest control the decision between differentiation and senescence in human neuroblastoma cells Proc. Natl. Acad. Sci. USA 98 2001 9396 9400